Author

Albert Dasí

University of OxfordORCID 0000-0002-8649-8203Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Pathology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:electrophysiology· 3 Organism:human· 3 Research Focus:drug response / drug discovery· 2 Approach:biophysical modeling· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Blanca RodrígueziD· 2 shared Ahmed F. RamadaniD· 1 shared Alfonso Bueno‐OrovioiD· 1 shared Amar J. AzadiD· 1 shared Amor Mia AlvioriD· 1 shared Andrew P. HolmesiD· 1 shared Anna Marie PriceiD· 1 shared Ashwin RoyiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

Blanca RodríguezORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

PhysiologyThe Journal of PhysiologyPeer-reviewedOct 17, 2026

Channelrhodopsin Ion Selectivity Determines Mechanisms and Efficacy of Optogenetic Defibrillation in Human Atria and Ventricles

Sophia Ohnemus, Albert Dasí, Ahmed F. Ramadan…·Franziska Schneider‐Warme

This study compares the defibrillation efficacy of different channelrhodopsins in human cardiac tissue using simulations, finding that ion selectivity affects arrhythmia termination mechanisms and success.

1 citation

humanelectrophysiology

𝕏 PostBluesky

PathologyCirculation Arrhythmia and ElectrophysiologyPeer-reviewedJun 25, 2025

Early atrial remodelling drives arrhythmia in Fabry Disease

Ashwin Roy, Christopher O’Shea, Albert Dasí…·Richard Paul Steeds

This study identifies early atrial remodelling as a driver of arrhythmia in Fabry Disease by combining ECG analysis, iPSC-derived cardiomyocytes, and in-silico modelling.

7 citationstop 3%

humanelectrophysiology

𝕏 PostBluesky

BioengineeringThe Journal of PhysiologyPeer-reviewedNov 18, 2024

Towards prospective in-silico trials in atrial fibrillation: the case of polypharmacological SK and K2P channel block

Albert Dasí, Lucas Arantes Berg, Hector Martinez‐Navarro…·Blanca Rodríguez

The paper uses in-silico trials to evaluate the efficacy of SK and K2P channel block in atrial fibrillation, finding that combined block significantly improves cardioversion success.

9 citations

humanelectrophysiology

𝕏 PostBluesky